HELEN OF TROY LTD (HELE) Fundamental Analysis & Valuation

NASDAQ:HELE • BMG4388N1065

Current stock price

14.6 USD
+0.11 (+0.76%)
At close:
14.64 USD
+0.04 (+0.27%)
After Hours:

This HELE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. HELE Profitability Analysis

1.1 Basic Checks

  • HELE had positive earnings in the past year.
  • HELE had a positive operating cash flow in the past year.
  • In the past 5 years HELE has always been profitable.
  • HELE had a positive operating cash flow in each of the past 5 years.
HELE Yearly Net Income VS EBIT VS OCF VS FCFHELE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • HELE has a worse Return On Assets (-33.86%) than 96.67% of its industry peers.
  • HELE has a worse Return On Equity (-92.99%) than 93.33% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 6.68%, HELE is in line with its industry, outperforming 55.00% of the companies in the same industry.
  • HELE had an Average Return On Invested Capital over the past 3 years of 7.78%. This is in line with the industry average of 9.19%.
Industry RankSector Rank
ROA -33.86%
ROE -92.99%
ROIC 6.68%
ROA(3y)4.94%
ROA(5y)6.79%
ROE(3y)9.09%
ROE(5y)12.93%
ROIC(3y)7.78%
ROIC(5y)9.49%
HELE Yearly ROA, ROE, ROICHELE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • In the last couple of years the Profit Margin of HELE has declined.
  • HELE's Operating Margin of 8.21% is in line compared to the rest of the industry. HELE outperforms 60.00% of its industry peers.
  • In the last couple of years the Operating Margin of HELE has declined.
  • HELE has a better Gross Margin (46.72%) than 85.00% of its industry peers.
  • HELE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.21%
PM (TTM) N/A
GM 46.72%
OM growth 3Y-3.04%
OM growth 5Y-2.95%
PM growth 3Y-13.62%
PM growth 5Y-6.17%
GM growth 3Y3.79%
GM growth 5Y2.19%
HELE Yearly Profit, Operating, Gross MarginsHELE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. HELE Health Analysis

2.1 Basic Checks

  • HELE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for HELE has been reduced compared to 1 year ago.
  • HELE has less shares outstanding than it did 5 years ago.
  • HELE has a worse debt/assets ratio than last year.
HELE Yearly Shares OutstandingHELE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
HELE Yearly Total Debt VS Total AssetsHELE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • HELE has an Altman-Z score of 1.63. This is a bad value and indicates that HELE is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.63, HELE is doing worse than 83.33% of the companies in the same industry.
  • HELE has a debt to FCF ratio of 15.97. This is a negative value and a sign of low solvency as HELE would need 15.97 years to pay back of all of its debts.
  • HELE has a Debt to FCF ratio (15.97) which is comparable to the rest of the industry.
  • HELE has a Debt/Equity ratio of 1.02. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.02, HELE is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 15.97
Altman-Z 1.63
ROIC/WACC0.8
WACC8.34%
HELE Yearly LT Debt VS Equity VS FCFHELE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • HELE has a Current Ratio of 1.81. This is a normal value and indicates that HELE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.81, HELE is doing worse than 71.67% of the companies in the same industry.
  • A Quick Ratio of 0.90 indicates that HELE may have some problems paying its short term obligations.
  • HELE has a Quick ratio of 0.90. This is in the lower half of the industry: HELE underperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 0.9
HELE Yearly Current Assets VS Current LiabilitesHELE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. HELE Growth Analysis

3.1 Past

  • The earnings per share for HELE have decreased strongly by -31.15% in the last year.
  • The Earnings Per Share has been decreasing by -4.99% on average over the past years.
  • Looking at the last year, HELE shows a decrease in Revenue. The Revenue has decreased by -5.69% in the last year.
  • Measured over the past years, HELE shows a small growth in Revenue. The Revenue has been growing by 2.24% on average per year.
EPS 1Y (TTM)-31.15%
EPS 3Y-16.48%
EPS 5Y-4.99%
EPS Q2Q%-35.96%
Revenue 1Y (TTM)-5.69%
Revenue growth 3Y-4.98%
Revenue growth 5Y2.24%
Sales Q2Q%-3.37%

3.2 Future

  • The Earnings Per Share is expected to decrease by -17.18% on average over the next years. This is quite bad
  • HELE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.25% yearly.
EPS Next Y-50.81%
EPS Next 2Y-30.78%
EPS Next 3Y-17.18%
EPS Next 5YN/A
Revenue Next Year-7.26%
Revenue Next 2Y-3.35%
Revenue Next 3Y-1.25%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HELE Yearly Revenue VS EstimatesHELE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
HELE Yearly EPS VS EstimatesHELE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

7

4. HELE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 2.90, which indicates a rather cheap valuation of HELE.
  • HELE's Price/Earnings ratio is rather cheap when compared to the industry. HELE is cheaper than 98.33% of the companies in the same industry.
  • HELE is valuated cheaply when we compare the Price/Earnings ratio to 25.60, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 4.23 indicates a rather cheap valuation of HELE.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HELE indicates a rather cheap valuation: HELE is cheaper than 96.67% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.84. HELE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.9
Fwd PE 4.23
HELE Price Earnings VS Forward Price EarningsHELE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HELE indicates a somewhat cheap valuation: HELE is cheaper than 73.33% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, HELE is valued cheaper than 90.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.03
EV/EBITDA 5.95
HELE Per share dataHELE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • A cheap valuation may be justified as HELE's earnings are expected to decrease with -17.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-30.78%
EPS Next 3Y-17.18%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HELE Dividend Analysis

5.1 Amount

  • HELE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HELE Fundamentals: All Metrics, Ratios and Statistics

HELEN OF TROY LTD

NASDAQ:HELE (4/2/2026, 8:00:01 PM)

After market: 14.64 +0.04 (+0.27%)

14.6

+0.11 (+0.76%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)01-08
Earnings (Next)04-24
Inst Owners100.92%
Inst Owner Change3.3%
Ins Owners1.38%
Ins Owner Change24.56%
Market Cap336.82M
Revenue(TTM)1.80B
Net Income(TTM)-792.50M
Analysts74.55
Price Target23.21 (58.97%)
Short Float %13.28%
Short Ratio4.67
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.95%
Min EPS beat(2)-2.08%
Max EPS beat(2)9.97%
EPS beat(4)1
Avg EPS beat(4)-12.41%
Min EPS beat(4)-52.71%
Max EPS beat(4)9.97%
EPS beat(8)4
Avg EPS beat(8)-8.68%
EPS beat(12)7
Avg EPS beat(12)-3.46%
EPS beat(16)11
Avg EPS beat(16)-0.36%
Revenue beat(2)1
Avg Revenue beat(2)0.46%
Min Revenue beat(2)-0.16%
Max Revenue beat(2)1.08%
Revenue beat(4)1
Avg Revenue beat(4)-2.08%
Min Revenue beat(4)-7.92%
Max Revenue beat(4)1.08%
Revenue beat(8)3
Avg Revenue beat(8)-2.13%
Revenue beat(12)5
Avg Revenue beat(12)-1.23%
Revenue beat(16)7
Avg Revenue beat(16)0.42%
PT rev (1m)0%
PT rev (3m)-5.21%
EPS NQ rev (1m)-1%
EPS NQ rev (3m)-45.96%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.94%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-1.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.22%
Valuation
Industry RankSector Rank
PE 2.9
Fwd PE 4.23
P/S 0.19
P/FCF 6.03
P/OCF 3.55
P/B 0.4
P/tB N/A
EV/EBITDA 5.95
EPS(TTM)5.04
EY34.52%
EPS(NY)3.45
Fwd EY23.63%
FCF(TTM)2.42
FCFY16.59%
OCF(TTM)4.11
OCFY28.14%
SpS78.12
BVpS36.94
TBVpS-3.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number64.72
Profitability
Industry RankSector Rank
ROA -33.86%
ROE -92.99%
ROCE 8.28%
ROIC 6.68%
ROICexc 6.78%
ROICexgc 14.36%
OM 8.21%
PM (TTM) N/A
GM 46.72%
FCFM 3.1%
ROA(3y)4.94%
ROA(5y)6.79%
ROE(3y)9.09%
ROE(5y)12.93%
ROIC(3y)7.78%
ROIC(5y)9.49%
ROICexc(3y)7.81%
ROICexc(5y)9.62%
ROICexgc(3y)23.08%
ROICexgc(5y)29.38%
ROCE(3y)9.64%
ROCE(5y)11.77%
ROICexgc growth 3Y-15.74%
ROICexgc growth 5Y-12.1%
ROICexc growth 3Y-13.74%
ROICexc growth 5Y-11.08%
OM growth 3Y-3.04%
OM growth 5Y-2.95%
PM growth 3Y-13.62%
PM growth 5Y-6.17%
GM growth 3Y3.79%
GM growth 5Y2.19%
F-Score3
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 15.97
Debt/EBITDA 4.3
Cap/Depr 72.11%
Cap/Sales 2.16%
Interest Coverage 250
Cash Conversion 46.94%
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 0.9
Altman-Z 1.63
F-Score3
WACC8.34%
ROIC/WACC0.8
Cap/Depr(3y)172.35%
Cap/Depr(5y)199.35%
Cap/Sales(3y)3.95%
Cap/Sales(5y)4.01%
Profit Quality(3y)83.41%
Profit Quality(5y)72.63%
High Growth Momentum
Growth
EPS 1Y (TTM)-31.15%
EPS 3Y-16.48%
EPS 5Y-4.99%
EPS Q2Q%-35.96%
EPS Next Y-50.81%
EPS Next 2Y-30.78%
EPS Next 3Y-17.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.69%
Revenue growth 3Y-4.98%
Revenue growth 5Y2.24%
Sales Q2Q%-3.37%
Revenue Next Year-7.26%
Revenue Next 2Y-3.35%
Revenue Next 3Y-1.25%
Revenue Next 5YN/A
EBIT growth 1Y-17.67%
EBIT growth 3Y-7.86%
EBIT growth 5Y-0.78%
EBIT Next Year-24.29%
EBIT Next 3Y-4.67%
EBIT Next 5YN/A
FCF growth 1Y-83.21%
FCF growth 3Y9.8%
FCF growth 5Y-19.99%
OCF growth 1Y-75.77%
OCF growth 3Y-7.01%
OCF growth 5Y-16.04%

HELEN OF TROY LTD / HELE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HELEN OF TROY LTD (HELE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to HELE.


Can you provide the valuation status for HELEN OF TROY LTD?

ChartMill assigns a valuation rating of 7 / 10 to HELEN OF TROY LTD (HELE). This can be considered as Undervalued.


Can you provide the profitability details for HELEN OF TROY LTD?

HELEN OF TROY LTD (HELE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of HELEN OF TROY LTD (HELE) stock?

The Price/Earnings (PE) ratio for HELEN OF TROY LTD (HELE) is 2.9 and the Price/Book (PB) ratio is 0.4.


What is the financial health of HELEN OF TROY LTD (HELE) stock?

The financial health rating of HELEN OF TROY LTD (HELE) is 2 / 10.